Skip to main content

UBS Group AG

Position in MBRX — Moleculin Biotech, Inc.

CIK 1610520 ZURICH, V8

Position in MBRX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$7,806
-$11,599 QoQ
Shares Held
3,409
-41.9% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MBRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in MBRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,806 3,409
2025-12-31 $19,405 5,863
2025-09-30 $2,101 3,965
2025-06-30 $2,412 7,989
2024-12-31 $15,196 8,939
2023-09-30 $85 200
2022-12-31 $11,917 11,243
2022-09-30 $11,070 10,444
2022-06-30 $2,396 1,653
2021-09-30 $4,209 1,403
2021-06-30 $3,930 1,071
2020-12-31 $29,270 36,726
2020-09-30 $50,858 62,556
2020-06-30 $46,016 47,538
2020-03-31 $20,677 33,898